OncLive | Bringing the Global Oncology Community Together

Gastrointestinal oncology experts highlight what they are most excited for at the upcoming International Society of Gastrointestinal Oncology 16th Annual Gastrointestinal Oncology Conference. Read More >>

Neoadjuvant and Frontline Studies Guide Malignant Melanoma Treatment

Osimertinib Continues to Gain Momentum as Frontline Therapy in EGFR+ NSCLC

Breakthrough Therapies Enrich Evolving CLL Paradigm

Emerging TNBC Agents Show Improved Patient Outcomes

Stereotactic Radiosurgery Can Improve Control of Brain Metastases

View More Stories >>

View Conference Coverage

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

2019 World Conference on Lung Cancer

Charlotte Plasma Cell Disorder Congress

State of the Science Summit on Breast Cancer in Long Island

Dr. Westbrook on 3-Year Follow-Up Data of the KRISTINE Trial in HER2+ Breast Cancer

Dr. Parekh on Using Genomics in Multiple Myeloma Treatment

Dr. Eradat on the Unmet Needs in CLL

Dr. Welslau on the Rationale for the REFLECT Trial in DLBCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Role of PARP Inhibitors in Prostate Cancer

Considerations for Genetic Testing in Prostate Cancer

Sequencing in Nonmetastatic and Metastatic CRPC

Patient Selection for Radium-223 in mCRPC

Reducing Risk of Fracture in Metastatic CRPC

AR-V7 as a Predictive Biomarker in Metastatic CRPC

Frontline Therapy in Newly Diagnosed Metastatic HSPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Acute GVHD: An Evolving Treatment Paradigm

Treating Acute GVHD With Novel Strategies

Novel Therapies for BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

The Future of Personalized Therapy in Advanced HCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates

Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL).

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

Breakthrough Status in Lung Cancer, Fast Track Status in Lung Cancer, and 2019 WCLC Highlights